TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $198 | -99.8% | 8,000 | -70.3% | 0.00% | 0.0% |
| Q2 2022 | $114,000 | -45.7% | 26,900 | +21.7% | 0.00% | 0.0% |
| Q1 2022 | $210,000 | -49.9% | 22,100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $419,000 | -45.4% | 22,100 | -4.3% | 0.00% | -66.7% |
| Q3 2021 | $768,000 | -24.4% | 23,100 | -11.8% | 0.00% | -25.0% |
| Q2 2021 | $1,016,000 | -37.1% | 26,200 | -21.8% | 0.00% | -33.3% |
| Q1 2021 | $1,614,000 | +39.9% | 33,500 | +50.9% | 0.01% | +50.0% |
| Q4 2020 | $1,154,000 | +176.7% | 22,200 | +42.3% | 0.00% | +100.0% |
| Q3 2020 | $417,000 | +358.2% | 15,600 | +231.9% | 0.00% | – |
| Q2 2020 | $91,000 | -62.7% | 4,700 | -79.4% | 0.00% | -100.0% |
| Q3 2014 | $244,000 | +388.0% | 22,800 | +330.2% | 0.00% | – |
| Q2 2014 | $50,000 | +35.1% | 5,300 | 0.0% | 0.00% | – |
| Q1 2014 | $37,000 | +76.2% | 5,300 | 0.0% | 0.00% | – |
| Q4 2013 | $21,000 | -30.0% | 5,300 | -10.2% | 0.00% | – |
| Q3 2013 | $30,000 | -21.1% | 5,900 | 0.0% | 0.00% | – |
| Q2 2013 | $38,000 | – | 5,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |